fosaprepitant dimeglumine
Generic: fosaprepitant dimeglumine
Labeler: qilu pharmaceutical co., ltd.Drug Facts
Product Profile
Brand Name
fosaprepitant dimeglumine
Generic Name
fosaprepitant dimeglumine
Labeler
qilu pharmaceutical co., ltd.
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
fosaprepitant dimeglumine 150 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
67184-0540
Product ID
67184-0540_62974dbd-affd-40b9-ad39-16e493f3cbec
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213106
Listing Expiration
2026-12-31
Marketing Start
2020-09-08
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
671840540
Hyphenated Format
67184-0540
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fosaprepitant dimeglumine (source: ndc)
Generic Name
fosaprepitant dimeglumine (source: ndc)
Application Number
ANDA213106 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/5mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "62974dbd-affd-40b9-ad39-16e493f3cbec", "openfda": {"upc": ["0367184054015"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["5bb41bcb-c775-4447-9bd0-d4c55ad110ea"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "67184-0540-1", "marketing_start_date": "20200908"}], "brand_name": "FOSAPREPITANT DIMEGLUMINE", "product_id": "67184-0540_62974dbd-affd-40b9-ad39-16e493f3cbec", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "67184-0540", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FOSAPREPITANT DIMEGLUMINE", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA213106", "marketing_category": "ANDA", "marketing_start_date": "20200908", "listing_expiration_date": "20261231"}